The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
Open accessAbstract
BACKGROUND & AIM: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in both adult and children. Currently there are no reliable methods to determine disease severity, monitor disease progression, or efficacy of therapy, other than an invasive liver biopsy. DESIGN: Choline Deficient L-Amino Acid (CDAA) and high fat diets were used as physiologically relevant mouse models of NAFLD. Circulating extracellular vesicles were isolated, fully characterized by proteomics and molecular analyses and compared to control groups. Liver-related microRNAs were isolated from purified extracellular vesicles and liver specimens. RESULTS: We observed statistically significant differences in the level of extracellular vesicles (EVs) in liver and blood between two control groups and NAFLD animals. Time-course studies showed that EV levels increase early during disease development and reflect changes in liver histolopathology. EV levels correlated with hepatocyte cell death (r2 = 0.64, p<0.05), fibrosis (r2 = 0.66, p<0.05) and pathological angiogenesis (r2 = 0.71, p<0.05). Extensive characterization of blood EVs identified both microparticles (MPs) and exosomes (EXO) present in blood of NAFLD animals. Proteomic analysis of blood EVs detected various differentially expressed proteins in NAFLD versus control animals. Moreover, unsupervised hierarchical clustering identified a signature that allowed for discrimination between NAFLD and controls. Finally, the liver appears to be an important source of circulating EVs in NAFLD animals as evidenced by the enrichment in blood with miR-122 and 192--two microRNAs previously described in chronic liver diseases, coupled with a corresponding decrease in expression of these microRNAs in the liver. CONCLUSIONS: These findings suggest a potential for using specific circulating EVs as sensitive and specific biomarkers for the noninvasive diagnosis and monitoring of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“Scoring analysis was based on NAFLD activity score (NAS) [25].”
MethodExtracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“The SEQUEST algorithm was used to match MS/MS spectra to peptides in the sequence databases [31, 32].”
MethodNonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Tabb, D. L., McDonald, W. H., & Yates, J. R. (2002) · Journal of Proteome Research · doi:10.1021/pr015504q · Cited by 1,367
Exosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
High‐fat Diets: Modeling the Metabolic Disorders of Human Obesity in Rodents
Buettner, R., Schölmerich, J., & Bollheimer, L. C. (2007) · Obesity · doi:10.1038/oby.2007.608 · Cited by 1,231
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device
Denzer, K., Kleijmeer, M. J., Heijnen, H. F. G., Stoorvogel, W., & Geuze, H. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.19.3365 · Cited by 1,067
Creating the Gene Ontology Resource: Design and Implementation
Consortium, T. G. O. (2001) · Genome Research · doi:10.1101/gr.180801 · Cited by 956
Exosomes: endosomal-derived vesicles shipping extracellular messages
Février, B., & Raposo, G. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.06.003 · Cited by 881
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Self-citationCreating the gene ontology resource: design and implementation.
Blake, J. A., Corradi, J., Eppig, J. T., Hill, D. P., Richardson, J. E., & Ringwald, M. (2001) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 826
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Characterization and Comprehensive Proteome Profiling of Exosomes Secreted by Hepatocytes
Conde-Vancells, J., Rodriguez-Suarez, E., Embade, N., Gil, D., Matthiesen, R., Valle, M., Elortza, F., Lu, S. C., Mato, J. M., & Falcon-Perez, J. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8004887 · Cited by 642
Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K., & Szabo, G. (2012) · Hepatology · doi:10.1002/hep.25873 · Cited by 631
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564 · cited 3×
“While in healthy individuals, miR-122 has been shown to circulate almost exclusively in a non-membrane bound form associated with a specific protein, Argonaute2 (Ago2), while a recent report demonstrated that in NAFLD patients the majority of serum miR-122 circulates in Ago2-free forms [33].”
BackgroundMethodInfluentialMolecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
McCormack, A. L., Schieltz, D. M., Goode, B., Yang, S., Barnes, G., Drubin, D., & Yates, J. R. (1997) · Analytical Chemistry · doi:10.1021/ac960799q · Cited by 523
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503 · cited 2×
“These time points have been shown to be associated with early, mild and established NAFLD, respectively [22].”
BackgroundMicroparticles: major transport vehicles for distinct microRNAs in circulation
Diehl, P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., Ziemann, M., Helbing, T., El-Osta, A., Jowett, J. B. M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs007 · Cited by 470
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future†
Wieckowska, A., McCullough, A. J., & Feldstein, A. E. (2007) · Hepatology · doi:10.1002/hep.21768 · Cited by 423
Self-citationTransfer of MicroRNAs by Embryonic Stem Cell Microvesicles
Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., & Farber, D. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004722 · Cited by 416
Microparticles, Vascular Function, and Atherothrombosis
Rautou, P.-E., Vion, A.-C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., & Boulanger, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.233163 · Cited by 376
Diagnosis and Therapy of Nonalcoholic Steatohepatitis
Torres, D. M., & Harrison, S. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.077 · Cited by 354
The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity
Li, Z., Berk, M., McIntyre, T. M., Gores, G. J., & Feldstein, A. E. (2008) · Hepatology · doi:10.1002/hep.22183 · Cited by 289
Self-citationPre-analytical and analytical issues in the analysis of blood microparticles
Yuana, Y., Bertina, R., & Osanto, S. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-09-0595 · Cited by 268
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice
Castoldi, M., Vujic Spasic, M., Altamura, S., Elmén, J., Lindow, M., Kiss, J., Stolte, J., Sparla, R., D’Alessandro, L. A., Klingmüller, U., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44883 · Cited by 247
Witek, R. P., Yang, L., Liu, R., Jung, Y., Omenetti, A., Syn, W., Choi, S. S., Cheong, Y., Fearing, C. M., Agboola, K. M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.066 · Cited by 210
Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., de Mollerat du Jeu, X., Mulya, A., Berk, M., Lazic, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 207
Self-citationKornek, M., Lynch, M., Mehta, S. H., Lai, M., Exley, M., Afdhal, N. H., & Schuppan, D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.031 · Cited by 203
Natural history of nonalcoholic steatohepatitis.
Liou, I. W., & Kowdley, K. V. (2006) · PubMed · doi:10.1097/01.mcg.0000168644.23697.31 · Cited by 169
Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis
Morel, O., Morel, N., Jesel, L., Freyssinet, J., & Toti, F. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-010-0239-3 · Cited by 166
Pan, Q., Ramakrishnaiah, V., Henry, S., Fouraschen, S., de Ruiter, P. E., Kwekkeboom, J., Tilanus, H. W., Janssen, H. L. A., & van der Laan, L. J. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300449 · Cited by 164
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Taylor, D. D., & Gercel-Taylor, C. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00142 · Cited by 158
Kornek, M., Popov, Y. V., Libermann, T. A., Afdhal, N. H., & Schuppan, D. (2010) · Hepatology · doi:10.1002/hep.23999 · Cited by 112
Non‐alcoholic steatohepatitis in children
Kerkar, N. N. (2004) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2004.00241.x · Cited by 100
Takaki, Y., Saito, Y., Takasugi, A., Toshimitsu, K., Yamada, S., Muramatsu, T., Kimura, M., Sugiyama, K., Suzuki, H., Arai, E., et al. (2014) · Cancer Science · doi:10.1111/cas.12498 · Cited by 92
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs
Garzetti, L., Menon, R., Finardi, A., Bergami, A., Sica, A., Martino, G., Comı, G., Verderio, C., Farina, C., & Furlan, R. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0913485 · Cited by 77
Takeshita, J., Mohler, E. R., Krishnamoorthy, P. M., Moore, J. S., Rogers, W. T., Zhang, L., Gelfand, J. M., & Mehta, N. N. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000507 · Cited by 70
Teoh, N., Ajamieh, H., Wong, H. J., Croft, K. D., Mori, T. A., ALLISON, A. C., & Farrell, G. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104376 · Cited by 56
Serpins, the vasculature, and viral therapeutics
Richardson, J., Viswanathan, K., & Lucas, A. (2006) · Frontiers in bioscience · doi:10.2741/1862 · Cited by 47
Kitade, M., Yoshiji, H., Noguchi, R., Ikenaka, Y., Kaji, K., Shirai, Y., Yamazaki, M., Uemura, M., Yamao, J., Fujimoto, M., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5193 · Cited by 44
AMASS: Algorithm for MSI Analysis by Semi-supervised Segmentation
Bruand, J., Alexandrov, T., Sistla, S., Wisztorski, M., Mériaux, C., Becker, M. S., Salzet, M., Fournier, I., Macagno, E. R., & Bafna, V. (2011) · Journal of Proteome Research · doi:10.1021/pr2005378 · Cited by 32
Automated Querying and Identification of Novel Peptides using MALDI Mass Spectrometric Imaging
Bruand, J., Sistla, S., Mériaux, C., Dorrestein, P. C., Gaasterland, T., Ghassemian, M., Wisztorski, M., Fournier, I., Salzet, M., Macagno, E. R., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr101159e · Cited by 31
Fink, K., Feldbrügge, L., Schwarz, M., Bourgeois, N., Helbing, T., Bode, C., Schwab, T., & Busch, H.-J. (2011) · Critical Care · doi:10.1186/cc10512 · Cited by 23
Cited by
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Metadata
- Authors
- Povero, D., Eguchi, A., Li, H., Johnson, C. D., Papouchado, B. G., Wree, A., Messer, K., & Feldstein, A. E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-03
- Volume
- 9
- Issue
- 12
- Pages
- e113651
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2052478346
- Cited by
- 272
- References
- 52
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.